Access cutting-edge rectal cancer treatment through this clinical trial at a research site in Commack. Study-provided care at no cost to qualified participants.
Access rectal cancer specialists in Commack at no cost
This study follows strict safety protocols and ethical guidelines
All study-related rectal cancer treatment provided free
The study researchers believe that a combination of the drugs trastuzumab and tucatinib, given with standard chemotherapy (capecitabine and oxaliplatin/FOLFOX), may help participants with rectal cancer.
Sponsor: Memorial Sloan Kettering Cancer Center
Check if you qualify for this rectal cancer clinical trial in Commack, NY
If you're searching for rectal cancer treatment options in Commack, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Commack research site is actively enrolling participants for this clinical trial. You'll receive care from experienced rectal cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.